Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Atkins

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|September 7, 2000
Re: randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year resultsC D Atkins
Lancet (London, England)|September 15, 1999
Postoperative radiotherapy in high-risk postmenopausal breast cancerC D Atkins
Journal of General Internal Medicine|November 5, 1997
Translating statistics for use in the clinicC D Atkins
The New England Journal of Medicine|February 12, 1998
Postmenopausal hormone therapy and mortalityC D Atkins
Journal of the National Cancer Institute|February 5, 1998
Re: relationship between the size and margin status of ductal carcinoma in situ of the breast and residual diseaseC D Atkins
Journal of the National Cancer Institute|March 10, 2001
Re: Efforts aimed at risk communication flourishC D Atkins
The New England Journal of Medicine|September 15, 1994
Adjuvant therapy for breast cancerC D Atkins
Journal of the National Cancer Institute|March 6, 1996
Inflammatory bowel disease associated with levamisole and fluorouracil chemotherapy for colon cancerC D Atkins
JAMA|May 21, 1997
Estrogen replacement therapy: new options, continuing concernsC D Atkins
Journal of the National Cancer Institute|September 2, 1999
Re: Colorectal cancer screening: sifting through the evidenceC D Atkins
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|September 7, 2000
Re: randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year resultsC D Atkins
Lancet (London, England)|September 15, 1999
Postoperative radiotherapy in high-risk postmenopausal breast cancerC D Atkins
Journal of General Internal Medicine|November 5, 1997
Translating statistics for use in the clinicC D Atkins
The New England Journal of Medicine|February 12, 1998
Postmenopausal hormone therapy and mortalityC D Atkins
Journal of the National Cancer Institute|February 5, 1998
Re: relationship between the size and margin status of ductal carcinoma in situ of the breast and residual diseaseC D Atkins
Journal of the National Cancer Institute|March 10, 2001
Re: Efforts aimed at risk communication flourishC D Atkins
The New England Journal of Medicine|September 15, 1994
Adjuvant therapy for breast cancerC D Atkins
Journal of the National Cancer Institute|March 6, 1996
Inflammatory bowel disease associated with levamisole and fluorouracil chemotherapy for colon cancerC D Atkins
JAMA|May 21, 1997
Estrogen replacement therapy: new options, continuing concernsC D Atkins
Journal of the National Cancer Institute|September 2, 1999
Re: Colorectal cancer screening: sifting through the evidenceC D Atkins
Pageof 5